EssilorLuxottica stock (FR0000121667): Morgan Stanley trims target to EUR 225
29.05.2026 - 21:06:01 | ad-hoc-news.deEssilorLuxottica shares were in focus after Morgan Stanley cut its price target to EUR 225 from EUR 315 and kept an Overweight rating, according to a report carried by TipRanks on 05/29/2026. The stock is listed on Euronext Paris, and the latest available market snapshot in the provided results shows EL.PA trading as an active French listing rather than a delisting candidate.
In Germany, the stock is also referenced through EL.PA-related coverage, while the company remains anchored in France's large-cap equity market. The home-country frame matters here because EssilorLuxottica is part of the French listed-universe that investors often track against the CAC 40 and Paris-based broker research.
As of: 05/29/2026
By the editorial team - specialized in equity coverage.
At a glance
- Name: EssilorLuxottica
- Sector/industry: Eyewear and vision care
- Headquarters/country: Charenton-le-Pont, France
- Core markets: Europe, North America, Asia-Pacific, and other international markets
- Key revenue drivers: Prescription lenses, frames, sunglasses, and retail eyewear distribution
- Home exchange/listing venue: Euronext Paris (EL.PA)
- Trading currency: EUR
EssilorLuxottica: core business model
EssilorLuxottica makes and sells eyewear and vision-care products through a vertically integrated model that spans lens technology, frames, sunglasses, and retail distribution, with demand driven by consumer replacement cycles and prescription needs.
Valuation metrics and multiples for EssilorLuxottica
One current valuation datapoint is the Morgan Stanley revision to EUR 225 from EUR 315, which was reported by TipRanks on 05/29/2026 and is directionally important because it marks a lower earnings-multiple view from a major sell-side house.
For chart context, Investing.com's technical page for EssilorLuxottica showed a neutral moving-average setup, with 6 buy signals and 6 sell signals in the snapshot included in the provided results. That does not replace fundamental valuation work, but it helps explain why the stock can attract both target-price cuts and a mixed technical read at the same time.
Additional context from the market-data result set shows the shares were still changing hands as an actively traded French equity rather than a completed take-private, which keeps the valuation debate centered on outlook and multiples rather than listing status.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Sentiment and reactions on EssilorLuxottica
Investors are likely to focus on how the lower Morgan Stanley target compares with other sell-side views and with the stock's current trading range.
Conclusion
The latest sell-side move keeps EssilorLuxottica in the spotlight in Paris, where valuation questions are being framed around a lower target rather than any change in listing status.
With the Friday module focused on valuation, the key question for the next trading sessions is whether the stock's fundamentals and market pricing can absorb the new target without a larger shift in sentiment.
Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.
So schätzen die Börsenprofis EssilorLuxottica Aktien ein!
Für. Immer. Kostenlos.
